Compare iShares MSCI Canada (TSX) (EWC) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Canada (TSX) vs Moderna, Inc. — how do they compare? iShares MSCI Canada (TSX) trades at $61.51, while Moderna, Inc. trades at $60.61 (market cap $24.18B). The key difference: iShares MSCI Canada (TSX) is trading nearer its 52-week high, Moderna, Inc. nearer its low. Which is the better fit depends on your goals.
| EWC | MRNA | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $61.51 | $81.80 |
52-Week Low | $47.00 | $22.36 |
Market Cap | — | $24.18B |
Enterprise Value | — | $20.33B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares MSCI Canada (TSX)
EWC is a country-specific ETF that tracks the performance of the Canadian equity market. It provides exposure to large and mid-sized companies in Canada, with heavy concentrations in financials and energy, including Royal Bank of Canada, Shopify, and Enbridge.
Read more on EWC →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
